Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News

Sanofi Reports Lower Q2 Earnings, But Lifts 2023 Outlook On New Drug Launches

By Vandana Singh
July 28, 8:49 AM
Sanofi SA (NASDAQ: SNY) reported a 1% decline in Q2 business operating in

SNY

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • M&A
  • Movers
  • News

AstraZeneca Q2 Earnings Beat Consensus Despite Zero COVID-19 Vaccine Sales, Stock Shoots Up

By Vandana Singh
July 28, 8:46 AM
AstraZeneca Plc's (NASDAQ: AZN) unit Alexion has 

AZN

Read More
1 minute read
  • Asset Sales
  • Equities
  • Large Cap
  • Markets
  • News

Toyota Divests $1.8B Stake In KDDI To Focus On EVs

By Lekha Gupta
July 28, 8:24 AM
Toyota Motor Corp (NYSE: TM) disclosed the sale of its stake in KDDI Corp (OTCPK: KDDIF) (OTCPK: KDDIY) for around 250 billion yen ($1.8 billion).

KDDIF

Read More
2 minute read
  • Buybacks
  • Dividends
  • Earnings
  • Equities
  • Large Cap
  • Markets
  • News

Chevron Posts Mixed Q2 Performance On Lower Upstream Realization

By Lekha Gupta
July 28, 8:08 AM
Oil giant Chevron Corp (NYSE: CVX) reported Q2 FY23 total revenues and other income of $48.896 billion, beating 

CVX

Read More
2 minute read
  • Equities
  • Government
  • Large Cap
  • News
  • Regulations
  • Sector ETFs
  • Top Stories

Big Banks To Bolster Capital by 16% Under Proposed US Regulations: Financial Stocks Fall

By Piero Cingari
July 27, 3:42 PM
In a significant overhaul of banking regulations since the 2008 financial crisis, U.S. regulators have proposed that large…

BAC

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • Large Cap
  • Markets
  • News
  • Price Target
  • Reiteration
  • Trading Ideas

Bright Future For Fiserv: Analysts Upgrade Price Target And EPS Estimates Following Q2 Earnings Beat

By Lekha Gupta
July 27, 3:01 PM
Many analysts boosted the price target of Fiserv Inc (NYSE: FI) after upbeat 

FI

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • Guidance
  • Large Cap
  • Markets
  • News
  • Price Target
  • Reiteration
  • Trading Ideas

Analysts Upbeat On Check Point Software’s Future: Price Targets Raised Post Q2 FY23 Results

By Lekha Gupta
July 27, 2:48 PM
Several analysts raised the price target of Check Point Software Technologies Ltd (NASDAQ: CHKP) after it 

CHKP

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • Large Cap
  • Markets
  • News
  • Price Target
  • Trading Ideas
  • Upgrades

Bullish On Boeing: Analyst Foresees Robust FCF Generation By Mid-2020s

By Lekha Gupta
July 27, 1:56 PM
B of A Securities analyst Ronald J.

BA

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Competition in Weight Loss Drug Space: Eli Lilly’s Obesity Drug Succeeds In Two Late-Stage Studies, Shows About 26% Weight Loss

By Vandana Singh
July 27, 1:08 PM
Eli Lilly And Co (NYSE: LLY) announced the results of two phase 3 tirzepatide studies in adults with obesity or overweight with weight-related comorbidities, 

LLY

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Merck Releases Encouraging Data From Two Late-Stage Studies For Pneumococcal Conjugate Vaccine

By Vandana Singh
July 27, 1:05 PM
Merck & Co Inc (NYSE: MRK) announced topline results from two Phase 3 trials evaluating V116, the company's investigational 21-valent pneumococcal conjugate vaccine in vaccine-naïve 

MRK

Posts pagination

Previous 1 … 250 251 252 … 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service